BeiGene, Ltd.
ONC
$223.20
$3.251.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.12B | 1.19B | 1.03B | 929.17M | 751.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12B | 1.19B | 1.03B | 929.17M | 751.65M |
| Cost of Revenue | 165.00M | 173.02M | 171.56M | 138.13M | 124.94M |
| Gross Profit | 952.28M | 1.02B | 854.56M | 791.03M | 626.72M |
| SG&A Expenses | 459.29M | 531.28M | 472.48M | 443.73M | 427.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -1.26M | 1.28M | -- | -- |
| Total Operating Expenses | 1.11B | 1.26B | 1.17B | 1.04B | 1.01B |
| Operating Income | 11.10M | -75.01M | -142.60M | -107.16M | -261.35M |
| Income Before Tax | 20.90M | -65.63M | -134.22M | -105.92M | -243.43M |
| Income Tax Expenses | 19.63M | 74.06M | 16.70M | 14.49M | 7.72M |
| Earnings from Continuing Operations | 1.27M | -139.70M | -150.92M | -120.41M | -251.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.27M | -139.70M | -150.92M | -120.41M | -251.15M |
| EBIT | 11.10M | -75.01M | -142.60M | -107.16M | -261.35M |
| EBITDA | 42.73M | -33.25M | -119.32M | -83.41M | -237.24M |
| EPS Basic | 0.15 | -17.09 | -18.69 | -14.95 | -31.31 |
| Normalized Basic EPS | 0.13 | -0.38 | -0.77 | -0.63 | -1.45 |
| EPS Diluted | 0.15 | -17.09 | -18.69 | -14.95 | -32.11 |
| Normalized Diluted EPS | 0.13 | -0.38 | -0.77 | -0.63 | -1.45 |
| Average Basic Shares Outstanding | 106.93M | 106.26M | 104.97M | 104.70M | 104.27M |
| Average Diluted Shares Outstanding | 8.55M | 8.17M | 8.07M | 8.05M | 8.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -9.60% | -- | -- |